The 10th SSNT Summit — Advances in Glomerulonephritis (GN) — takes place on 6–7 November 2026 at the Crowne Plaza Riyadh RDC Hotel (Siwar Hall), organised by the Saudi Society of Nephrology and Transplantation (SSN&T). The summit is accredited for 15 CME hours and registration is open through the society's events platform at ssnt-events.com.
Now in its tenth edition, the SSNT Summit has become the society's flagship scientific meeting, each year focusing on a single high-impact theme in kidney disease. The 2026 edition is dedicated to glomerulonephritis — one of the most rapidly evolving areas of nephrology, with new complement inhibitors, targeted immunotherapies and updated KDIGO guidance reshaping the management of IgA nephropathy, lupus nephritis, ANCA-associated vasculitis and other glomerular diseases.
The programme brings together national and international faculty for state-of-the-art lectures, case-based discussions and interactive sessions covering diagnosis, biopsy interpretation, biomarkers and the latest treatment algorithms, with a strong emphasis on practical decision-making for the practising nephrologist.
The SSN&T, founded in 2001 under the initiative of King Saud University, is the Kingdom's principal professional body for kidney disease and transplantation, and publisher of the Saudi Journal of Kidney Diseases and Transplantation. The summit is aimed at nephrologists, transplant physicians, internists, pathologists, trainees and allied renal health professionals from across Saudi Arabia and the Gulf region.
